America's Medicine Cabinet: Why US Dependence on Indian Pharma Has Soared by 70% Post-Pandemic
A Breath of Relief: How Trump's Drug Tariffs Spare India's Generic Pharma Giants
Trump's Tariff Tempest: Why a 100% Drug Tax Could Sink India's Pharma Giants and Ignite a US Healthcare Crisis
Trump's Bold Move: 100% Tariff on Branded Drugs Set to Shake Global Pharma, What It Means for India
India's Pharmaceutical Powerhouse Under Siege: Navigating Trump's Tariff Tempest
Trump's Tariff Twist: Generics Spared, But India's Export Horizon Remains Cloudy
Trump's Looming 100% Pharma Tariff: A Catastrophic Blow for India's Global Pharmacy?
A Game-Changer in HIV Treatment: Generic Drug Promises Unprecedented Affordability
The Enduring Saga of Drug Prices: Trump's Lingering Shadow on Healthcare Affordability
Lupin's Latest Triumph: US FDA Greenlight for HIV Drug Ignites Stock Rally
Trump's Rx for Disaster: Why a Paracetamol Ban Is a Perilous Prescription
India Delivers Major Blow to Novartis: Blockbuster Heart Drug Entresto Patent Revoked
Revolutionizing Healthcare: Government Unlocks Wider Access to Affordable Medicines with Bold New Policy
The Hidden Truth: America's Deep Reliance on Overseas Drug Manufacturing
Amneal Pharmaceuticals Secures Landmark FDA Approval for Generic Risperdal Consta
Trump's Tariff Tangle: Will His 10% Plan Hike Your Drug Costs?
Trump's Bold Plan to Slash Drug Costs with Tariffs: A Risky Bet for American Consumers?
The Unsung Heroes: How Indian Pharma Dodged Trump's Tariff Storm
Decoding the Paradox: Why Indian Pharma Stocks Are Plummeting Even After US Tariff Relief
A New Era for Actinic Keratosis Treatment: Extrovis and Dr. Reddy's Unveil Authorized Generic of CARAC® Cream